IBDEI22U ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35214,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,35214,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,35214,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,35215,0)
 ;;=G20.^^131^1700^25
 ;;^UTILITY(U,$J,358.3,35215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35215,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,35215,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,35215,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,35216,0)
 ;;=G31.01^^131^1700^26
 ;;^UTILITY(U,$J,358.3,35216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35216,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,35216,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,35216,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,35217,0)
 ;;=G23.1^^131^1700^28
 ;;^UTILITY(U,$J,358.3,35217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35217,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,35217,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,35217,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,35218,0)
 ;;=Z79.2^^131^1701^1
 ;;^UTILITY(U,$J,358.3,35218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35218,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,35218,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,35218,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,35219,0)
 ;;=Z79.01^^131^1701^2
 ;;^UTILITY(U,$J,358.3,35219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35219,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,35219,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,35219,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,35220,0)
 ;;=Z79.02^^131^1701^3
 ;;^UTILITY(U,$J,358.3,35220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35220,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,35220,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,35220,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,35221,0)
 ;;=Z79.82^^131^1701^4
 ;;^UTILITY(U,$J,358.3,35221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35221,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,35221,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,35221,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,35222,0)
 ;;=Z79.4^^131^1701^5
 ;;^UTILITY(U,$J,358.3,35222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35222,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,35222,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,35222,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,35223,0)
 ;;=Z79.1^^131^1701^7
 ;;^UTILITY(U,$J,358.3,35223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35223,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,35223,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,35223,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,35224,0)
 ;;=Z79.891^^131^1701^8
 ;;^UTILITY(U,$J,358.3,35224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35224,1,3,0)
 ;;=3^Opiate Analgesic
 ;;^UTILITY(U,$J,358.3,35224,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,35224,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,35225,0)
 ;;=Z79.51^^131^1701^9
 ;;^UTILITY(U,$J,358.3,35225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35225,1,3,0)
 ;;=3^Steroids-Inhaled
 ;;^UTILITY(U,$J,358.3,35225,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,35225,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,35226,0)
 ;;=Z79.52^^131^1701^10
 ;;^UTILITY(U,$J,358.3,35226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35226,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,35226,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,35226,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,35227,0)
 ;;=Z79.899^^131^1701^6
 ;;^UTILITY(U,$J,358.3,35227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35227,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,35227,1,4,0)
 ;;=4^Z79.899
